Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
BHVN Stock — Biohaven Ltd.
Biohaven Ltd. (BHVN)
Updated November 17, 2026.
BHVN is a stock. Total return is 76.7% over the past 4.2 years, 32.3 points behind SPY at 109.0%.
Biohaven Ltd. is a biopharmaceutical company focused on discovering, developing, and commercializing treatments across immunology, neuroscience, and oncology, with a pipeline including therapies in clinical trials for conditions such as Parkinson's disease, epilepsy, obesity, and various cancers, as well as preclinical candidates for autoimmune and neurological disorders. The company does not currently distribute to shareholders. Biohaven appeals to investors with a high risk tolerance seeking exposure to early-stage drug development, as its value depends on the success of its clinical programs rather than current profitability or income.
BHVN performance versus SPY
Total return is 76.7% over the past 4.2 years, 32.3 points behind SPY at 109.0%. Over the past year its total return — price change plus distributions reinvested — is 36.5%. Its deepest 1-year drawdown was 41.2%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | 19.7% | — |
| 3M | -4.9% | — |
| 6M | 51.9% | — |
| YTD | 14.3% | — |
| 1Y | 36.5% | — |
| 2Y CAGR | — | -46.70% |
| 3Y CAGR | — | -24.60% |
| Since inception 2022-09-23 · 4.2 years | 76.7% | 14.70% |
BHVN key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 09/23/2022
- Distribution frequency
- None
- Last close
- $13.24 (as of 2026-11-17)
- Market cap
- $2,000,018,260
- Average volume
- 1,567,879
- Beta
- 3.135
- Payout ratio
- 0.0%
- EPS
- -$3.77
How Dividend Vision calculates returns
Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
BHVN risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 41.2%.
Who may consider BHVN — and who may not
It is a weaker fit for investors who need monthly cash flow (BHVN does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on BHVN
Frequently asked questions
Does BHVN pay monthly?
No. BHVN does not currently distribute.
When does BHVN pay a dividend?
BHVN does not currently distribute.
How has BHVN performed?
Total return is 76.7% over the past 4.2 years, 32.3 points behind SPY at 109.0%. Over the past year its total return — price change plus distributions reinvested — is 36.5%. Its deepest 1-year drawdown was 41.2%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.